aspirin has been researched along with Pulmonary Arterial Remodeling in 6 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The goal of this study was to encapsulate Aspirin-Triggered Resolvin D1 (AT-RvD1) into a degradable biomaterial in order to elucidate the effects of sustained, localized delivery in a model of sterile inflammation." | 3.85 | Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling. ( Botchwey, EA; Olingy, CE; San Emeterio, CL; Sok, MCP; Tria, MC, 2017) |
| " This study aimed to evaluate the effects of long-term administration of losartan, aspirin, and atorvastatin on vascular remodeling in juvenile spontaneously hypertensive rats (SHRs)." | 1.91 | Effects of Long-Term Intervention with Losartan, Aspirin and Atorvastatin on Vascular Remodeling in Juvenile Spontaneously Hypertensive Rats. ( Dong, B; Dong, S; Li, L; Liu, Q; Shen, J; Yang, K; Zhao, Y; Zhou, X; Zhu, D, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Q | 1 |
| Dong, S | 1 |
| Zhou, X | 1 |
| Zhao, Y | 1 |
| Dong, B | 1 |
| Shen, J | 1 |
| Yang, K | 1 |
| Li, L | 1 |
| Zhu, D | 1 |
| Huang, N | 1 |
| Zhu, TT | 1 |
| Liu, T | 1 |
| Ge, XY | 1 |
| Wang, D | 1 |
| Liu, H | 2 |
| Zhu, GX | 1 |
| Zhang, Z | 1 |
| Hu, CP | 1 |
| Fisher, CL | 1 |
| Demel, SL | 1 |
| Tara, S | 1 |
| Kurobe, H | 1 |
| de Dios Ruiz Rosado, J | 1 |
| Best, CA | 1 |
| Shoji, T | 1 |
| Mahler, N | 1 |
| Yi, T | 1 |
| Lee, YU | 1 |
| Sugiura, T | 1 |
| Hibino, N | 1 |
| Partida-Sanchez, S | 1 |
| Breuer, CK | 1 |
| Shinoka, T | 1 |
| Gao, H | 1 |
| Cheng, Y | 1 |
| Zong, L | 1 |
| Huang, L | 1 |
| Qiao, C | 1 |
| Li, W | 1 |
| Gong, B | 1 |
| Hu, J | 1 |
| Wang, X | 1 |
| Zhao, C | 1 |
| Sok, MCP | 1 |
| Tria, MC | 1 |
| Olingy, CE | 1 |
| San Emeterio, CL | 1 |
| Botchwey, EA | 1 |
1 review available for aspirin and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Nonsteroidal Anti-Inflammatory Drugs: A Potential Pharmacological Treatment for Intracranial Aneurysm.
Topics: Animals; Aspirin; Cerebral Arteries; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dilatat | 2019 |
5 other studies available for aspirin and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Effects of Long-Term Intervention with Losartan, Aspirin and Atorvastatin on Vascular Remodeling in Juvenile Spontaneously Hypertensive Rats.
Topics: Animals; Antihypertensive Agents; Aspirin; Atorvastatin; Blood Pressure; Collagen; Hypertension; Int | 2023 |
Aspirin ameliorates pulmonary vascular remodeling in pulmonary hypertension by dampening endothelial-to-mesenchymal transition.
Topics: Animals; Aspirin; Endothelium; Epithelial-Mesenchymal Transition; Hypertension, Pulmonary; Rats; Sma | 2021 |
Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model.
Topics: Absorbable Implants; Animals; Aspirin; Blood Vessel Prosthesis; Cell Proliferation; Cilostazol; Dise | 2015 |
Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
Topics: Animals; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Flavonoids; Hypertension, Pulmonary; Hy | 2017 |
Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling.
Topics: Animals; Aspirin; Biocompatible Materials; Cytokines; Docosahexaenoic Acids; Drug Delivery Systems; | 2017 |